| Modulation of neurotrophic signaling pathways by polyphenols F Moosavi, R Hosseini, L Saso, O Firuzi Drug design, development and therapy, 23-42, 2015 | 310 | 2015 |
| HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers F Moosavi, E Giovannetti, L Saso, O Firuzi Critical reviews in clinical laboratory sciences 56 (8), 533-566, 2019 | 159 | 2019 |
| Plant glutathione S-transferase classification, structure and evolution S Mohsenzadeh, M Esmaeili, F Moosavi, M Shahrtash, B Saffari, ... African Journal of Biotechnology 10 (42), 8160-8165, 2011 | 87 | 2011 |
| Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer M Mortazavi, F Moosavi, M Martini, E Giovannetti, O Firuzi Critical reviews in oncology/hematology 176, 103749, 2022 | 85 | 2022 |
| Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review Z Haghighijoo, L Zamani, F Moosavi, S Emami European journal of medicinal chemistry 227, 113949, 2022 | 49 | 2022 |
| Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer F Moosavi, E Giovannetti, GJ Peters, O Firuzi Critical Reviews in Oncology/hematology 160, 103234, 2021 | 46 | 2021 |
| Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met T Damghani, F Moosavi, M Khoshneviszadeh, M Mortazavi, S Pirhadi, ... Scientific Reports 11 (1), 3644, 2021 | 37 | 2021 |
| Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents F Moosavi, R Hosseini, H Rajaian, T Silva, DM e Silva, L Saso, N Edraki, ... Bioorganic & Medicinal Chemistry 25 (12), 3235-3246, 2017 | 30 | 2017 |
| Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3, 4-dihydropyrimidin-2 (1H)-one C5 amide derivatives F Moosavi, A Ebadi, M Mohabbati, T Damghani, M Mortazavi, R Miri, ... European Journal of Pharmacology 894, 173850, 2021 | 22 | 2021 |
| Caffeic acid alkyl amide derivatives ameliorate oxidative stress and modulate ERK1/2 and AKT signaling pathways in a rat model of diabetic retinopathy M Fathalipour, M Eghtedari, F Borges, T Silva, F Moosavi, O Firuzi, ... Chemistry & Biodiversity 16 (12), e1900405, 2019 | 21 | 2019 |
| Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors M Mortazavi, M Divar, T Damghani, F Moosavi, L Saso, S Pirhadi, ... Frontiers in Chemistry 10, 969559, 2022 | 16 | 2022 |
| Novel quinazoline-1, 2, 3-triazole hybrids with anticancer and MET kinase targeting properties M Mortazavi, M Eskandari, F Moosavi, T Damghani, M Khoshneviszadeh, ... Scientific Reports 13 (1), 14685, 2023 | 15 | 2023 |
| Evaluation of the FDA-approved kinase inhibitors to uncover the potential repurposing candidates targeting ABC transporters in multidrug-resistant cancer cells: an in silico … A Poustforoosh, F Moosavi Journal of Biomolecular Structure and Dynamics 42 (24), 13650-13662, 2024 | 13 | 2024 |
| Discovery of neurotrophic agents based on hydroxycinnamic acid scaffold R Hosseini, F Moosavi, H Rajaian, T Silva, D Magalhaes e Silva, ... Chemical Biology & Drug Design 88 (6), 926-937, 2016 | 13 | 2016 |
| Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors M Divar, N Edraki, T Damghani, F Moosavi, M Mohabbati, A Alipour, ... Bioorganic & Medicinal Chemistry 90, 117367, 2023 | 8 | 2023 |
| Modulation of ERK1/2 and Akt pathways involved in the neurotrophic action of caffeic acid alkyl esters R Hosseini, F Moosavi, T Silva, H Rajaian, SY Hosseini, S Bina, L Saso, ... Molecules 23 (12), 3340, 2018 | 8 | 2018 |
| Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters S Nazari, F Mosaffa, A Poustforoosh, M Mortazavi, L Saso, O Firuzi, ... Toxicology and Applied Pharmacology 484, 116866, 2024 | 6 | 2024 |
| Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients A Abbaspour, M Dehghani, M Setayesh, M Tavakkoli, HA Rostamipour, ... Cancer Chemotherapy and Pharmacology 92 (6), 475-483, 2023 | 5 | 2023 |
| In silico screening of c-Met tyrosine kinase inhibitors targeting nucleotide and drug-substrate binding sites of ABCB1 as potential MDR reversal agents F Moosavi, T Damghani, S Ghazi, S Pirhadi Journal of Receptors and Signal Transduction, 1-13, 2022 | 5 | 2022 |
| Analysis of synonymous codon usage bias and nucleotide and amino acid composition in 13 species of Flaviviridae F Moosavi, H Mohabatkar, S Mohsenzadeh JOURNAL OF CELL AND MOLECULAR RESEARCH 3 (1), 1-11, 2011 | 5 | 2011 |
